GlaxoSmithKline News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.05.25	Biotech Stocks Facing FDA Decision In May 2025 (RTTNews)
30.04.25	GSK Plc Q1 Results Rise; Confirms FY25 Outlook (RTTNews)
17.04.25	GSK's Penmenvy Receives US Advisory Committee's Positive Backing For 5-in-1 Meningococcal Vaccine (RTTNews)
07.04.25	ABL Bio And GSK Partner To Develop Innovative Treatments For Neurodegenerative Diseases (RTTNews)
26.03.25	FDA Approves GSK' Blujepa For Treating Uncomplicated Urinary Tract Infections In Women & Adolescents (RTTNews)
03.03.25	GSK: Depemokimab Shows Significant Improvements For CRSwNP Patients In Phase III Trials (RTTNews)
26.02.25	Zymeworks Receives $14 Million Cash Research Milestone Payment From GSK (RTTNews)
17.02.25	FDA Approves GSK's Penmenvy, 5-in-1 Meningococcal Vaccine For MenABCWY Protection (RTTNews)
05.02.25	GSK Stock Up On Q4 Results, Positive Outlook; Plans To Buyback GBP 2 Bln Shares (RTTNews)
05.02.25	GSK FY24 Core Operating Profit Rises, Turnover Up 7% At CER; Increases 2031 Sales Outlook (RTTNews)
31.01.25	Biotech Stocks Facing FDA Decision In February 2025 (RTTNews)
20.01.25	GSK: European Commission Expands Jemperli Plus Chemotherapy Approval - Quick Facts (RTTNews)
13.01.25	GSK To Acquire GIST Drug Developer IDRx For Up To $1.15 Bln Cash (RTTNews)
10.01.25	GSK's Shingrix New Prefilled Syringe Presentation Accepted For Review By FDA (RTTNews)
09.01.25	FDA Urges Guillain-Barré Syndrome Warning On Labels Of RSV Vaccines Abrysvo And Arexvy (RTTNews)
07.01.25	FDA Grants Breakthrough Therapy Designation To GSK's GSK5764227 For Bone Cancer (RTTNews)
20.12.24	GSK Reports Headline Results From FIRST-ENGOT-OV44 Phase III Trial - Quick Facts (RTTNews)
09.12.24	GSK: FDA Accepts For Review Submission For New Indication Of Nucala In COPD (RTTNews)
05.12.24	GSK, Zhifei Revise And Extend Strategic Vaccine Collaboration In China (RTTNews)
25.11.24	GSK :FDA Accepts Blenrep Combination For Review In Treatment Of Relapsed/Refractory Multiple Myeloma (RTTNews)
22.11.24	GSK Plc Announces Regulatory Expansion For Arexvy In Japan To Include Adults Aged 50-59 (RTTNews)
14.11.24	GSK Reports Positive Headline Results From DREAMM-7 Phase III Trial (RTTNews)
30.10.24	GSK Q3 Results Down, Sees FY24 Outlook At Mid Range; Stock Drops (RTTNews)
30.10.24	GSK Q3 Pre-tax Profit Drops; Confirms 2024 Outlook - Quick Facts (RTTNews)
16.10.24	GSK Plc: NDA For Gepotidacin Granted Priority Review By FDA - Quick Facts (RTTNews)
10.10.24	GSK Reaches $2.2 Bln Settlement Over Zantac Liability Cases (RTTNews)
08.10.24	GSK Announces Positive Data From AReSVi-006 Phase III Trial For RSV Vaccine Arexvy (RTTNews)
24.09.24	GSK: CHMP Issues Positive Opinion On New Fully Liquid Presentation Of Menveo Meningococcal Vaccine (RTTNews)
18.09.24	GSK Reports Positive Data From Co-administration Of RSV And Shingles Vaccines (RTTNews)
18.09.24	GSK Settles 2 Cases In California Against Zantac (RTTNews)
17.09.24	GSK: Japan Accepts For Review NDA For Blenrep Combinations In Relapsed/refractory Multiple Myeloma (RTTNews)
13.09.24	GSK : Blenrep Combination Receives Breakthrough Therapy Designation For Multiple Myeloma In China (RTTNews)
12.09.24	GSK Announces Promising Data From Phase II Seasonal Influenza MRNA Vaccine Program (RTTNews)
06.09.24	GSK : Phase III Trial Of Nucala In Chronic Obstructive Pulmonary Disease Meets Primary Endpoint (RTTNews)
28.08.24	GSK Welcomes Delaware Supreme Court's Review Of Expert Evidence Ruling (RTTNews)
28.08.24	GSK: Japanese Ministry Of Health, Labour And Welfare Grants SENKU Designation For Bepirovirsen (RTTNews)
28.08.24	Japan Approves GSK's Nucala For Treating Adults With Chronic Rhinosinusitis With Nasal Polyps (RTTNews)
20.08.24	GSK :GSK5764227 Gets FDA Breakthrough Therapy Designation For Extensive-stage Small-cell Lung Cancer (RTTNews)
16.08.24	GSK To Seek Dismissal Of Wilson Case In Florida After Favorable Daubert Ruling (RTTNews)
02.08.24	GSK Reports Expanded Approval For Jemperli Plus Chemotherapy (RTTNews)
31.07.24	ViiV Healthcare Reports Positive Data For 2-Drug Regimen DOVATO In HIV-1 Treatment (RTTNews)
31.07.24	GSK Q2 Profit Declines, Sales Rise; Lifts FY24 Guidance; Declares Dividend (RTTNews)
29.07.24	GSK Reaches Confidential Settlement With Ronald Kimbrow Involving Ranitidine (RTTNews)
29.07.24	Biotech Stocks Facing FDA Decision In August 2024 (RTTNews)
29.07.24	GSK's RSV Vaccine Arexvy Gets Positive CHMP Opinion For Adults Aged 50-59 At Increased Risk (RTTNews)
23.07.24	SCYNEXIS To Receive $10 Mln Milestone Payment From GSK For Completed Clinical Study Report (RTTNews)
11.07.24	GSK Plans To Distribute Over 36 Mln Doses Of Trivalent Influenza Vaccines In The US (RTTNews)
03.07.24	GSK Acquires Global Rights For MRNA Vaccines For Influenza & COVID-19 In CureVac Deal - Quick Facts (RTTNews)
10.06.24	GSK's Arexvy RSV Vaccine Gets FDA's Approval For Adults Aged 50-59 (RTTNews)
03.06.24	GSK Plc: Jemperli Trial Shows Unprecedented Results (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	45.19	4.63 %	K V
Logitech Intl	64.26	3.58 %	K V
Holcim	93.86	2.47 %	K V
Geberit	582.80	2.21 %	K V
Part Grp Hldg	1’099.00	2.19 %	K V
Swiss Re	148.85	0.74 %	K V
Zurich Insur Gr	586.00	0.62 %	K V
Novartis	94.21	0.45 %	K V
Nestle	87.60	-0.16 %	K V
Swisscom	548.00	-0.36 %	K V

mehr

27.07.22		GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an
06.06.22		GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten
31.05.22		GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal
27.04.22		GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen
13.04.22		GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent
28.02.22		GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft
10.02.22		CureVac-Aktie steigt: CureVac beginnt Phase-1-Studie mit Grippeimpfstoff-Kandidat
09.02.22		GSK-Aktie gibt dennoch nach: GlaxoSmithKline verdient im Schlussquartal deutlich mehr

27.07.22

GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an

06.06.22

GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten

31.05.22

GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal

27.04.22

GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen

13.04.22

GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent

28.02.22

GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft